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ABSTRAK 
 
 
CIRI-CIRI KLINIKAL YANG CEMAS BAGI PENYAKIT MELIOIDOSIS DI 
HOSPITAL USM: 
KAJIAN SEPULUH TAHUN 
 
Pengenalan 
Melioidosis muncul sebagai satu masalah global, bagaimanapun, beberapa 
kajian telah diterangkan secara khusus tentang ciri-ciri klinikal dan status akhir 
kesihatan pesakit apabila dirawat di Jabatan Kecemasan (ED). Melioidosis ialah 
penyakit berjangkit tropika disebabkan oleh bakteria Gram-negatif Burkholderia 
pseudomallei. Diagnosis segera ialah satu cabaran besar kepada doktor di ED kerana 
kepelbagaian ciri-ciri klinikal penyakit melioidosis ini. Organ yang paling kerap terjejas 
oleh organisma ini adalah paru-paru. Walau bagaimanapun, adalah amat sukar untuk 
membezakan secara klinikal penyebab radang paru-paru oleh melioidosis dengan 
organisma lain. 
 
Diandaikan bahawa hujan lebat berserta angin kencang membawa B. 
pseudomallei yang tertanam ke permukaan tanah; selepas itu, mereka lebih cenderung 
untuk disedut pada kepekatan yang tinggi dan menyebabkan kejutan septik yang teruk 
dan kematian awal. Kajian ini bertujuan untuk menentukan ciri-ciri klinikal dan profil 
makmal pesakit melioidosis yang datang ke ED, Hospital Universiti Sains Malaysia 
(HUSM), Kelantan. 
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Metodologi 
Kajian ini merupakan kajian kohort retrospektif (penelitian rekod). Semua 
pesakit yang datang ke ED, HUSM dari Januari 2001 hingga Disember 2011 dengan 
sampel positif untuk melioidosis telah dimasukkan dalam kajian ini. Data dikumpul 
melalui pangkalan data berkomputer mikrobiologi hospital (WHO program-net) untuk 
calon individu dengan melioidosis. Data yang telah dimasukkan, dianalisis dengan 
menggunakan perisian SPSS versi 19.0 untuk menjana statistik deskriptif dan analitik. 
 
Keputusan 
Seramai 86 orang pesakit telah diteliti rekod mereka. Median pesakit berumur 
51 tahun, 79.1% ialah lelaki dan 96.5% berbangsa Melayu. 91.9% daripada jumlah 
pesakit telah mengalami demam, diikuti dengan batuk (62.8%), dan sesak nafas 
(25.6%). Majoriti organ yang terlibat adalah paru-paru (65.1%), tisu lembut (19.8%), 
hati (18.6%), dan sendi (11.6%). Berdasarkan gejala tersebut, terdapat hubungan yang 
signifikan untuk batuk (p = 0.02), sesak nafas (p = 0.001) dan jangkitan tisu lembut (p = 
0.030) dengan status akhir kesihatan pesakit. 
 
Walaupun faktor-faktor risiko dijangkiti melioidosis yang paling kerap ialah 
diabetes (79.1%), diikuti dengan musim hujan (55.8%) dan terdedah kepada tanah 
(36%), tidak ada kaitan yang signifikan antara faktor-faktor risiko dan status akhir 
kesihatan pesakit. Semua penemuan fizikal didapati ada kaitan dengan status akhir 
kesihatan pesakit kecuali suhu badan (p> 0.05). Secara keseluruhan, semua profil 
makmal pesakit melioidosis adalah tinggi. Kaitan yang signifikan adalah pada urea (p = 
0.001), kreatinin (p = 0.001), AST (p = 0.002) dan PT / INR (p = 0.001). 
 
xi 
 
Dari segi penggunaan antibiotik secara empirikal, dan kelewatan masa sebelum 
memulakan terapi, tidak ada kaitan yang signifikan (p> 0.05) dengan status akhir 
kesihatan pesakit. Ketiadaan sesak nafas (SOB) (p = 0.017), tekanan darah sistolik (p = 
0.049), tekanan darah diastolik (p = 0,018) dan PT / INR (p = 0.012) merupakan faktor 
penentu utama bagi pesakit untuk pulih daripada melioidosis. Oleh itu, model faktor 
penentu untuk pemulihan di kalangan pesakit melioidosis adalah: 
 
Pemulihan (z) = 5.161 (Tiada SOB) -0.074 (SBP) + 0.186 (DBP) – 7.010 (PT / INR) 
 
 
Formula Nagelkerke R Square menunjukkan bahawa kira-kira 76% daripada 
variasi dalam pembolehubah hasil (pemulihan) dijelaskan oleh model logistik ini dan 
ketepatan keseluruhan model ini untuk meramalkan subjek untuk kembali sembuh 
(dengan kebarangkalian yang diramalkan sebanyak 0.5 atau lebih besar) adalah 87.7% . 
 
Kesimpulan 
Ciri-ciri klinikal dan profil makmal boleh meramalkan status akhir kesihatan 
pesakit mengidap melioiosis. Tidak ada hubungan yang signifikan antara penggunaan 
antibiotik empirikal dan kelewatan masa sebelum memulakan terapi antimelioid dengan 
status akhir kesihatan pesakit yang mengidap melioidosis. 
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ABSTRACT 
 
 
 
EMERGENCY PRESENTATIONS OF MELIOIDOSIS IN HOSPITAL USM: 
A TEN-YEAR REVIEW 
 
Introduction 
Melioidosis emerged as a global problem, however, few studies have 
specifically described the clinical characteristics and outcomes when patients with 
melioidosis are treated at an Emergency Department (ED). Melioidosis is a tropical 
infectious disease caused by Gram-negative bacteria Burkholderia pseudomallei. The 
prompt diagnosis of melioidosis is a great challenge to ED physicians because of the 
disease’s diverse clinical presentations. The most common organ affected by this 
organism is lungs. However, it is very difficult to differentiate clinically the pneumonia 
causes by melioidosis with other organisms. 
 
It is postulated that heavy rainfall with strong winds brings buried B. 
pseudomallei isolates to the soil surface; thereafter, they are more likely to be inhaled at 
high concentrations of the bacteria resulted in severe septic shock and early mortality. 
This study aimed to determine the clinical characteristics and laboratory profiles of 
patients with melioidosis that attended ED, Hospital Universiti Sains Malaysia 
(HUSM), Kelantan. 
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Methodology 
This is a retrospective cohort study (record review). All patients presented to 
ED, HUSM from January 2001 till December 2011 with positive culture for melioidosis 
were included in the study. Data collected via hospital’s computerized microbiology 
database (WHO-net program) for candidate individuals with melioidosis. Data entered 
and analyzed by using SPSS version 19.0 to generate descriptive and analytical 
statistics.  
 
Results 
A total of 86 patients were reviewed. Median age of the cases was 51 years old, 
males (79.1%) and Malays (96.5%). About 91.9% of the patients presented with fever, 
followed with cough (62.8%), and shortness of breath (25.6%). Majority of the organ 
involved were lung (65.1%), soft tissue (19.8%), liver (18.6%), and joints (11.6%). 
Base on symptoms, there were significant association for cough (p=0.02), shortness of 
breath (p=0.001) and abscess (p=0.030) with the outcomes. 
 
Even though the most common risk factors were diabetes (79.1%), followed 
with rainy season (55.8%) and soil exposure (36%), there was no significant 
associations between risk factors and outcomes. All physical findings is significantly 
associated with the outcomes except for temperature (p>0.05). Overall, all laboratory 
profiles of melioidosis patients were deranged or prolonged. The only significant 
association were urea (p=0.001), creatinine (p=0.001), AST (p=0.002) and PT/INR 
(p=0.001).  
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In term of empirical antibiotic usage and time lag before initiation of therapy, 
there was no significance associations (p>0.05) with the outcomes. The absence of 
shortness of breath (p=0.017), systolic blood pressure (p=0.049), diastolic blood 
pressure (p=0.018) and PT/INR (p=0.012) were the main predictor for the patients to 
recover from melioidosis. Therefore, predictor model for recovery among melioidosis 
patient is: 
 
Recovery (z) = 5.161 (No SOB) -0.074 (SBP) + 0.186 (DBP) – 7.010 (PT/INR) 
 
The Nagelkerke R Square shows that about 76% of the variation in the outcome 
variable (recovery) is explained by this logistic model and the overall accuracy of this 
model to predict subjects to recover (with a predicted probability of 0.5 or greater) is 
87.7%. 
 
Conclusion 
The clinical presentations and laboratory profiles can predict the outcomes of 
patient with melioidosis. There was no significant association between empirical usage 
of antibiotics and time lag before initiation of antimelioid therapy with the outcomes of 
melioidosis patients.  
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CHAPTER 1: INTRODUCTION 
 
Melioidosis emerged as a global problem, however, few studies have specifically 
described the clinical characteristics and outcomes when patients with melioidosis are 
treated at ED (Wu et al., 2012). Melioidosis is a tropical infectious disease caused by 
Gram-negative bacteria Burkholderia pseudomallei. This soil-borne disease is endemic in 
Southeast Asia and Northern Australia. Melioidosis has a diverse spectrum of clinical 
presentations and can affect any organ. It is important to define the demographic profiles, 
clinical characteristics and outcomes of melioidosis because of the regional differences 
have been described in the prevalence of organ involvement (Malczewski et al., 2005). 
 
The prompt diagnosis of melioidosis is a great challenge to ED physicians 
because of the disease’s diverse clinical presentations. A lack of clinical awareness and 
delays in obtaining bacteriologic identification that can result in inappropriate empiric 
antimicrobial selection and may place patients at a greater risk for mortality. A study by 
Deris et al(2010), indicated the early use of appropriate empirical antibiotics in ED may 
reduce the mortality due to bacteremic melioidosis. The most common organ affected by 
this organism is lungs. However, it is very difficult to differentiate clinically the 
pneumonia causes by melioidosis with other organisms. 
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Previous matched care-control study showed that the independent risk factors of 
pneumonic melioidosis were visiting the ED during the rainy season, poor control of 
glucose levels, and arriving in the ED in shock (Kung et al., 2011). Currie and Jacups 
also indicated that heavy rainfall in the 14 days before admission was an independent risk 
factor for pneumonia, septic shock, and death in patients with melioidosis (Currie et al., 
2003). It is postulated that heavy rainfall with strong winds brings buried B. pseudomallei 
isolates to the soil surface; thereafter, they are more likely to be inhaled at high 
concentrations of the bacteria resulted in severe septic shock and early mortality.  
Kelantan State, which is located in the northeastern part of Malaysia, has a heavy 
monsoon season from November to March every year. This state is located in what is 
known as the Malaysian rice bowl and has more than 60,000 hectares of paddy fields. 
Thousands of people are at risk of contracting B. pseudomallei, which is a great public 
health concern and an important cause of community acquired sepsis in the northeastern 
part of Malaysia (Deris et al., 2010). However, not many publications on meliodosis come 
from Malaysia. This study aimed to determine the clinical characteristics and laboratory 
profiles of patients with melioidosis that attended ED, HUSM, Kelantan. 
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CHAPTER 2. LITERATURE REVIEW 
 
2.1 SOCIO-DEMOGRAPHICS OF THE CASES 
 
Deris et al. (2010) reported that twenty patients (74.1%) were male. The mean age 
was 46.8 + 20.0 years with the youngest was 15 days old and the eldest was 80 years old.  
Based on study done by Ahmad et al. (2009), at Hospital Temerloh involving 33 patients 
in 2years, male is more prone to get melioidosis with ratio of 8:3 and age ranged from 40 
to 65 years old. Relation with soil contact, there was no specific occupation correlated 
with the infection; however all three female patients were housewives. It was postulated 
that higher incidence of males with melioidosis may be due to their greater exposure to 
soil or contaminated water while engaging in agricultural activities.  
 
Another study done in Pahang from January 2000 to June  2003  by How et 
al.(2005). That study found that 78.5% of the cases were male and Malay contributed 
83% of the cases. Majority of the cases in Pahang aged 45 – 65 years old. In an another 
larger study by Puthucheary et al.(2009) in Malaysia, comprehensive review of 98 
septicaemic and 43 nonsepticaemic cases were studied over a period of 35 years, there is 
a bimodal distribution of age in both groups of patients. Ranged from 17 days to 79 years 
of age, increase in the 10-30 years old group possibly reflects the greater environmental 
exposure during outdoor recreational activities.  
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Both males and female had the peak age-specific incidence occurred from 41 – 59 
years. In every published case series on melioidosis, males have outnumbered females 
but the proportions varied considerably which likely reflects involvement in activities 
which lead to exposure to contaminated soil and water. In his study, the M:F ratio was 
found to be 3.2:1. No conclusion can be drawn regarding the correlation with the race 
group even the morbidity rate was highest amongst the Indians, lowest in Malays and 
intermediate in the Chinese. It is possible that the groups differed in their frequency of 
activities resulting in occupational and environmental exposure to soil and water.  
 
In Brunei, a 6 years study by Pande et al.(2011) involving 14 out of 48 culture-
positive patients (29%) were diagnosed with melioidosis of the extremities during the 
study period. Male population still predominantly involve as 13 male patients and one 
female patient, with a median age of 45 (range 14–55) years. A prospective observational 
study involving 31 patients by Ramamoorthi et al.(2013), the male to female ratio was 
3:1. The median age was 48 years which fifty-two percent of patients were in the age 
group 41 to 60 years. By descriptive analysis, thirty-two of patients were agriculturists 
but no further analysis done to see the significance of it in correlation with melioidosis.  
 
Study by Wu et al.(2012) involving total of 25 patients from emergency 
department in Taiwan, the mean age was 54 years which range between 35 to 87 years. 
Among them, 92% were male with ration of 23:2. 
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2.2 CLINICAL PRESENTATIONS OF MELIODOSIS CASES 
 
A study by Deris et al.(2010) reported that the main clinical presentation was 
fever that occurred in 23 (85.2%) patients. Two patients presented with scrotal swelling, 
which later one developed Fournier's Gangrene. This presentation also reported by 
Puthucheary et al.(2009) The majority of patients presented with fever, the duration of 
which varied from l-2 d to 2-6 months, but in the latter the fever was not continuous. 
Pyrexia of unknown origin was diagnosed in two patients.  
 
Similar result reported by Ramamoorthi et al.(2013), 87% (n = 27) of patients 
presented with fever, followed by cough in 35% (n = 11); breathlessness in 29% (n = 9) 
and jaundice in 20% (n = 6) of patients. The other presenting complaints were, skin and 
soft tissue swelling, joint pain-arthralgia, oliguria, abdominal pain, and a discharging 
axillary sinus. The pattern of fever varies, 16% of patients had fever of one-week 
duration; 55% of patients had fever duration of 7 to 30 days; 10% of patients had fever 
duration of 31 to 60 days. 
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2.3 ORGAN INVOLVEMENT IN MELIODOSIS 
 
Deris et al.(2010) reported that lung involvement occurs in eighteen patients 
(66.7%) and three patients had liver abscess. Two patients presented with scrotal 
swelling, which later one of it complicated with Fournier's Gangrene. This also supported 
by Hassan et al.(2010), the study reported that pneumonia accounted for 42.06% of 
primary diagnoses followed by soft tissue abscess. Similar as studied by Wu et al.(2012), 
the most common infection site was the lungs (52%), followed by the genitourinary tract 
(28%) and the joints (16%). There was more than one site of infection in nine of the 
patients (36%). 
 
A study in India by Ramamoorthi et al.(2013), most common organ involved was 
lung. Thirty-five percent (n = 11) of patients had pneumonia; 20% (n = 6) had pleural 
effusion; 3% (n = 1) had a mediastinal mass and 3% (n = 1) had a pyopneumothorax. The 
other organs involved as clinical presentation were multiple liver abscesses, splenic 
abscess, osteomyelitis, septic arthritis, cervical lymphadenopathy, submandibular lymph 
node abscess, parotid abscess, subcutaneous abscess in the back, and discharging axillary 
sinus. A 20 years prospective study by B.J. Currie et al.(2010) in Australia reported that 
the principal presentation was pneumonia in 278 (51%). Another presentations were 
genitourinary infection in 76 (14%), skin infection in 68 (13%), bacteremia without 
evident focus in 59 (11%), septic arthritis/osteomyelitis in 20 (4%) and neurological 
melioidosis in 14 (3%). 
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2.4 RISK FACTORS FOR MELIODOSIS 
 
The most common risk factors were diabetes mellitus (79.1%) which some of 
them were newly diagnosed during that admission, followed with rainy season (55.8%), 
soil exposure (36.0%), chronic renal failure (10.5%) and malignancy (7.0%) (Deris et al., 
2010). A total of 25 patients with melioidosis studied by Wu et al.(2012) in Taiwan, 84% 
were found to have at least one underlying condition, and diabetes mellitus (in 68% of 
patients) was the most common disease. Four patients (16%) had soil exposure, two were 
farmers and two were construction workers. Sixteen of the patients (64%) presented 
during the rainy season in Taiwan (between June and September). 
 
Based on multivariable conditional logistic regression analysis, activities 
associated with a risk of melioidosis included working in a rice field, other activities 
associated with exposure to soil or water, an open wound, eating food contaminated with 
soil or dust, drinking untreated water, outdoor exposure to rain, water inhalation , current 
smoking and steroid intake. This organism B. pseudomallei, was detected in water 
source(s) consumed by 7% of cases and 3% of controls (Limmathurotsakul et al., 2013) 
The risk for developing and dying from melioidosis is high in patient with underlying 
diabetes, which occurring in 57% of all diagnosed cases. The other risk factors such as 
chronic renal failure, chronic lung disease, HIV, and other immunocompromised state 
were statistically not significant.  But there were linear associations between cases and 
deaths with monthly rainfall. (Hassan et al., 2010) 
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2.5 PHYSICAL AND LABORATORY FINDINGS IN MELIODOSIS 
 
Study by Wu et al.(2012) in Taiwan show that the presence of band-form 
leukocytes ( p=0.001), increased serum creatinine ( p=0.037), and shock on arrival ( 
p=0.005) were significantly more common among patients with early mortality. The 
other elevated blood parameters in patients with melioidosis were aspartate transaminase 
(AST) and blood glucose, but not contributing to early mortality. 
 
Melioidosis was associated with activation of coagulation, suppression of anti-
coagulation, and abnormalities of fibrinolysis. A study by Peacock et al.(2011), there was 
no haemostatic alterations were influenced by pre-existing diabetes. In the absence of 
infection, diabetes has a procoagulant effect. Even though diabetes itself is associated 
with multiple abnormalities of coagulation, anticoagulation and fibrinolysis, these 
changes are not detectable when superimposed on the background of larger abnormalities 
attributable to B. pseudomallei sepsis. 
 
The blood parameters in patients with melioidosis may differ depending on 
severity of the disease during presentation to seek treatment. A study by Ramamoorthi et 
al.(2013) in India reported that 19 patients (61%) had total leucocyte count of more than 
11,000 (cells/mm3).  
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2.6 MANAGEMENT OF MELIODOSIS 
 
Treatment for melioidosis is usually divided into two phases. The first phase or 
acute phase, the aim is to prevent death from overwhelming sepsis. The parenteral drugs 
are given more than 10days. In the second phase or eradication phase, relapse prevention 
is done by completing with oral drugs for a total of 20weeks. Each treatment is tailored to 
individual patient’s needs. Ceftazidime is the main drug used for treatment of melioidosis 
in acute-phase treatment, carbapenems are reserved for severe infections or treatment 
failures. For the eradication phase, Trimethoprim/sulfamethoxazole (co-trimoxazole) is 
preferred, and co-amoxiclav as an alternative treatment (Dance et al., 2014).  
 
Good multicentre collaboration across the main endemic region of Southeast Asia and 
northern Australia had make incremental improvements in treating melioidosis. Instead 
of two phase of treatment strategy, there is most recent consensus on post exposure 
prophylaxis (phase 0). The type, severity and antimicrobial susceptibility of infection 
determined the best combination of agents used, the duration of therapy and need of 
adjunct modalities (Inglis et al., 2010).  
 
Treatment of melioidosis lengthy and require an intensive phase (parenteral 
ceftazidime, amoxicillin–clavulanic acid or meropenem) and an eradication phase (oral 
trimethoprim–sulfamethoxazole). Although resistance is still relatively rare, the 
increasing usage of antibiotics in endemic regions may compromise the therapeutic 
efficacies by emergence of resistance (Schweizer et al., 2012) 
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In a study by Crowe et al.(2014) in Australia, 234 isolates of B. pseudomallei 
obtained from the first positive clinical specimen from 234 consecutive patients 
diagnosed with melioidosis were reviewed. All isolates were sensitive to meropenem and 
ceftazidime. The resistance of B. pseudomallei to ceftazidime and/or meropenem is very 
rare and clinicians can be confident in the current melioidosis treatment guidelines. 
 
2.7 ASSOCIATED FACTOR FOR MELIODOSIS OUTCOME 
 
Melioidosis is very difficult to cure and has a mortality rate of up to 40%. Patient 
with a positive blood culture for B. pseudomallei taken at the end of the first and/or 
second week after hospitalization is a strong prognostic factor for death. The follow-up 
blood cultures in patients with melioidosis need to be highlighted (Limmathurotsakul et 
al., 2011). 
 
Pneumonia was the primary diagnosis for the patient with culture-confirmed 
melioidosis. The majority of it presented with acute or subacute presentations rather than 
chronic disease. According to multivariate logistic regression model, the risk factors for 
presentation with primary pneumonia were rheumatic heart disease or congestive cardiac 
failure, chronic obstructive pulmonary disease, smoking, and diabetes mellitus, with 
P<.05 for these conditions. Compared to patients with other primary presentations, those 
presenting with pneumonia more frequently developed septic shock (33% vs 10%; 
P<.001) and died (20% vs 8%; P<.001). Multilobar pneumonia occurred in 28% of 
patients and was associated with greater mortality (32%) than in those with single-lobe 
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pneumonia (14%; P<.001). Melioidosis pneumonia, particularly among those with 
multilobar disease is a rapidly progressive illness with high mortality. Once the risk 
factors have been identified, early diagnosis and treatment should be our priorities. 
(Meumann et al., 2012) 
 
 
2.8 PREDICTOR FOR MELIODOSIS OUTCOME (RECOVERY) 
 
A study by Currie et al.(2010), the seasonality was not a significant independent 
predictor of mortality. The presence of risk factors such as diabetes, hazardous alcohol 
use, chronic lung or renal disease and older age were the predictor of mortality from 
melioidosis. Diabetes as a predictor of mortality in melioidosis was also supported by 
Sapian et al.(2012).  
 
Among those with mortality, seven were villagers and one was rescuer. The case 
fatality rates were higher in the villagers group which was 100% (7 out of 7) compared to 
33.3% (1 out of 3) in professional rescuers. The high morbidity and mortality rate were 
probably due to they are relatively older, with median age of 55.5 years as compared to 
professional group (30 years). 
 
In univariate analysis, risk factors for death were signs of shock or multiorgan 
failure (p<0.001), blood stream infection (p<0.001) and not receiving appropriate empiric 
therapy (p<0.001). Total of thirty (52%) patients died; 19(63%) of them died within 1 
 12 
 
week after admission. Improvement of sepsis care and early administration of effective 
drugs such as ceftazidime, carbapenems, and amoxicillin/clavulanic acid are potential 
interventions that can decrease risk factors for death in melioidosis patients (Vlieghe et 
al., 2011). 
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CHAPTER 3: RESEARCH OBJECTIVES 
 
3.1 RESEARCH QUESTION 
3.1.1 How does most of melioidosis present at ED? 
3.1.2  Is the initial clinical presentation and laboratory profiles predict the outcome 
of melioidosis? 
 
3.2 GENERAL OBJECTIVES 
To determine the predictors and outcomes of melioidosis patients presented to ED, 
HUSM. 
 
3.3 SPECIFIC OBJECTIVES 
3.3.1  To describe the clinical presentations and laboratory profiles of melioidosis 
patient presented to ED. 
3.3.2  To evaluate the association of clinical presentations and laboratory profiles 
of melioidosis patients presented to ED and their outcomes.  
3.3.3  To determine the prevalence of empirical antibiotic usage for melioidosis in 
ED, time lag before antimelioid therapy and association with the outcome. 
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3.4 NULL HYPOTHESIS 
3.4.1 There was no association between the predictors (clinical presentations and 
laboratory profiles) of melioidosis patients presented to ED with their 
outcomes. 
3.4.2 There was no association between the empirical antibiotic usages for 
melioidosis in ED and time lag before antimelioid therapy with their 
outcomes. 
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CHAPTER 4: RESEARCH METHODOLOGY 
 
4.1 STUDY DESIGN:  
A retrospective cohort study (record review) 
 
4.2 POPULATION AND SAMPLE :  
4.2.1 Source population :  
- All patients presented to ED, HUSM between January 2001- December 
2011 who fulfilled inclusion criteria.  
4.2.2 Inclusion criteria: 
- All confirmed cases of melioidosis between January 2001- December 2011 
will be selected for the study. 
- Attended or admitted via ED for the symptoms or sign possible related to 
melioidosis. The patient that culture may be taken from other health facility 
but attended/admitted for the same episode of melioidosis will be included 
in the study. 
- Patient attended ED for other reason that not related to melioidosis, and no 
signs or symptoms can be associated with melioidosis will be included in the 
study if the culture were positive. 
4.2.3 Exclusion criteria:  
- Melioidosis patients that are not attended/admitted through ED. 
- Unavailability of medical records to review. 
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4.3 SAMPLE SIZE 
All culture positive B pseudomallei during study period will be included.  
 
4.4 STUDY APPROVAL 
This study was approved by Human Research Ethics Committee (HREC) Universiti 
Sains Malaysia on 15th January 2013 with reference to Appendix B. Consent for 
record tracing were obtained from Director office, HUSM on 5th February 2013 
with reference to Appendix C. 
 
4.5 DATA COLLECTION 
Hospital’s computerized microbiology database (WHO-net program) for candidate 
individuals with melioidosis, and these patients were included in this study. 
 
4.6 DATA ENTRY AND STATISTICAL ANALYSIS 
 
4.6.1 DATA ENTRY 
 
Data will be entered and analysed by using SPSS version 19.0 
 
4.6.2 DESCRIPTIVE ANALYSIS 
 
For demographic data & clinical characteristic 
Expected Result (Dummy Table) 
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i) Socio-demographic Data 
Variables Numerical 
 Mean (SD) 
Categorical 
Frequency (%) 
Age   
Gender   
Race   
Occupation   
Clinical Presentation   
 
4.6.3 STATISTICAL ANALYSIS 
 
Results were expressed in terms of the number and percentage or the 
interquartile range (IQR). For categorical variables, the differences in patient 
characteristics and associated factors were tested by Chi-square test. For continuous 
variables, the Mann-Whitney U Test was used. The p value of ≤ 0.05 was 
considered significant. All analyses were done using SPSS software (SPSS, 
Chicago, Illinois, USA) in the Medical Informatics’ Laboratory, School of Medical 
Sciences, University Sciences Malaysia. 
 
Objective 1:  
Descriptive statistics 
Objective 2:  
Chi-Square, Mann-Whitney U Test, and Multiple Logistic Regression 
Objective 3:  
Chi-Square, Mann-Whitney U Test, and Multiple Logistic Regression 
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4.7  TERM DEFINITIONS 
1. Melioidosis confirmed cases 
Culture grown from any specimen was positively identified as B. pseudomallei. One 
episode of melioidosis is presumed when the cultures were positive without 
normalized of clinical/laboratory symptoms or signs of infection (Wu et al. 2012). 
2. Bacteremia  
The presence of bacteria in the blood that confirmed by; at least one positive blood 
culture from clinically septic patient (Deris et al.2010). 
3. Soil exposure  
Soil exposure is defined as a contact with soil during either occupational or 
recreational activity such as gardening, farming, camping, or construction work 
(Wu et al. 2012). 
4. Shock 
Shock on arrival is defined as a systolic blood pressure below 90 mmHg or a 
decrease of more than 30 mmHg in comparison with the patient’s baseline systolic 
blood pressure detected at the ED, coupled with clinical evidence of peripheral 
hypoperfusion (Kung et al. 2011). 
5. Early mortality 
Early mortality is defined as death within 48 hours after presentation at the 
ED (Kung et al. 2011). 
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6. Sepsis  
The systemic response to infection, manifested by the presence of two or more of 
the conditions listed as criteria for systemic inflammatory response system (SIRS). 
Note: SIRS may be caused by inflammatory conditions other than infection 
(Peacock et al, 2011) 
7. Appropriate antibiotics 
Appropriate empiric antibiotic therapy at the ED was defined as the start of empiric 
antibiotic treatment using imipenem, meropenem, ceftazidime, 
amoxicillin/clavulanic acid or trimethoprim-sulfamethoxazole, which might be 
potentially effective against B. pseudomallei (Wu et al. 2012). 
8. Outcomes 
Either patient recovers, or death due to melioidosis, or death due to other causes. 
Death due to melioidosis is divided into early mortality (death within 48 hours after 
presentation at the ED) or late mortality (death more than 48 hours after 
presentation at the ED) (Kung et al. 2011). 
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4.8 FLOW CHART  
 
 
SOURCE POPULATION 
Inclusion Criteria                                                                                      Exclusion Criteria 
 
 
 
                     
    
DATA COLLECTION 
                                           
 
DATA ENTRY AND 
ANALYSIS 
                   
        
REPORT AND PAPER 
PREPARATION 
                      
 
 
SUBMISSION  OF DISSERTATION 
REPORT 
                              
 
CRITERIA NOT MET CRITERIA  MET 
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CHAPTER 5: RESULTS 
 
 
5.0 INTRODUCTION 
 
Retrospectively, record of 86 patients confirmed cases by positive culture of 
melioidosis presented to ED HUSM, Kubang Kerian, Kelantan, Malaysia from January 2001 
to December 2011 were reviewed and included in the study. Finally, data collected were 
analyzed using the SPSS version 19.0 software to generate the descriptive and analytical 
statistics. 
 
5.1 DESCRIPTIVE ANALYSIS 
 
5.1.1 Socio-demographic characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Gender distributions among the cases 
 
 
 
 
 
 
68 (79.1%) 
18 (20.9%) 
Male 
Female 
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Figure 5.2 Ethnic distributions among the cases 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Occupation distributions among the cases 
 
 
 
83 (96.5%) 
3 (3.5%) 
Malay 
Chinese 
33 (38.4%) 
12 
(14.0%) 
41 (47.7%) 
Soil related 
Non-soil related 
Not known 
 23 
 
 
 
Table 5.1 Socio-demographic characteristics distribution of the patients  
 
*values are expressed in median (IQR) 
 
 
Overall, this study involved 86 cases based on inclusion and exclusion criteria with 
the median age were 51 years old.  Majority of the cases were male (79.1%) and based on the 
ethnicity, Malay contributed 96.5% of the cases and followed by Chinese (3.5%). Only 
38.4% of the cases work in the soil related occupation. 
 
 
 
 
 
 
 
 
Characteristics Number (percentage) 
 n (%) 
number of cases 
 
86 
*Age (years), median (IQR) 
 
51.00 (39.75,60.00) 
Gender 
   Male 
   Female 
 
68 (79.1) 
18 (20.9) 
   
Ethnicity 
   Malay 
   Chinese 
 
83 (96.5) 
3 (3.5) 
 
Occupation 
   Soil related 
   Non-soil related 
   Not known 
 
33 (38.4) 
12 (14.0) 
41 (47.7) 
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5.1.2 Clinical presentations 
 
 
Table 5.2 Clinical presentations of patients with melioidosis 
 
 
 
Clinical presentations Number (percentage) 
n (%) 
Fever   
 Yes   79 (91.9) 
 No 7 (8.1) 
Cough  
 Yes   32 (37.2) 
 No 54 (62.8) 
Shortness of Breath  
 Yes   22 (25.6) 
 No 64 (74.4) 
Altered Mental State  
 Yes   2 (2.3) 
 No 84 (97.7) 
Seizures  
 Yes   4 (4.7) 
 No 82 (95.3) 
Urinary Tract Infection  
 Yes   5 (5.8) 
 No 81 (94.2) 
Abscess  
 Yes   14 (16.3) 
 No 72 (83.7) 
Infected wound  
 Yes   2 (2.3) 
 No 84 (97.7) 
Cellulitis  
 Yes 7 (8.1) 
 No 79 (91.9) 
Joint Pain  
 Yes 4 (4.7) 
 No 82 (95.3) 
Vomiting  
 Yes 2 (2.3) 
 No 84 (97.7) 
Diarrhoea  
 Yes 1 (1.2) 
 No 85 (98.8) 
Jaundice  
 Yes 8 (9.3) 
 No 78 (90.7) 
